Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Glioma | Q9NZM4 | map05214 | viomycin | 135398671 | drug-path |
| SNARE interactions in vesicular transport | R-HSA-428625 | map04130 | viomycin | 135398671 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | viomycin | 135398671 | drug-path |
| Non-small cell lung cancer | R-HSA-5619066 | map05223 | viomycin | 135398671 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | viomycin | 135398671 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | hexylcaine | 6839 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | hexylcaine | 6839 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | hexylcaine | 6839 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | hexylcaine | 6839 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | hexylcaine | 6839 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | hexylcaine | 6839 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | benzethonium chloride | 38258 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | benzethonium chloride | 38258 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | benzethonium chloride | 38258 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | benzethonium chloride | 38258 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | benzethonium chloride | 38258 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | proadifen | 667484 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | proadifen | 667484 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | proadifen | 667484 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | proadifen | 667484 | drug-path |